5 pharmaceuticals in the nature of coagulation antagonists for the treatment and prevention of myocardial infarction, stroke, atherosclerosis, angina, and conditions of the cardiovascular and circulatory systems
The mark consists of a highly stylized representation of a structural drawing of a chemical receptor site.